Here’s Why Shares in This Former Pfizer Target Are Tanking

A sign is seen at an AstraZeneca site in Macclesfield

Health Here’s Why Shares in This Former Pfizer Target Are Tanking Shares in AstraZeneca, the U.K.-Swedish pharma company that Pfizer pfe once tried to buy for $118 billion, fell by 16% Thursday after it said the cancer drug on which it had pinned high hopes had

Health The 30 Best Workplaces in Health Care The health care industry is rapidly changing as technology advances, regulations shift, and payment structures change. But the chance to help patients and save lives is still at the core of why

Key Speakers At 16th Nikkei Global Management Forum 2014

Health Teva Pharmaceuticals CEO Vigodman Is Stepping Down The chief executive of Teva Pharmaceutical Industries, the world’s biggest maker of generic drugs, stepped down after three years following a series of strategic stumbles and legal and

Health A New Suitor Has Reportedly Replaced J&J in This Over $20 Billion Biotech Deal Switzerland’s Actelion is in talks with French drugmaker Sanofi about a deal, sources said on Wednesday, after U.S. healthcare group Johnson & Johnson abandoned efforts to buy the

A Tea-Party supporter protest outside th

Finance The 3 Best Health Care and Pharma Stocks for 2017—Whatever Happens to Obamacare To understand the uncertainty over what Donald Trump’s presidency will mean for health care, look no further than the stock market: The day after the election the Nasdaq Biotechnology Index surged

Leadership Bill Ackman Says Valeant Might Change Its Name to Fix Its Reputation Valeant Pharmaceuticals International, the drugmaker that became a poster child for high drug prices during the U.S. election season, may change its name to help boost its reputation, board member

Finance Donald Trump’s Presidency Could Unleash a Pharma Merger Boom Biotechnology companies, whose U.S. shares soared Wednesday after Republican Donald Trump’s presidential election, may soon see another benefit: an uptick in biotech M&A. A potential influx

Health Pharma Stocks Are Soaring After Donald Trump’s Victory Pharmaceutical stocks surged in Europe on Wednesday as Republican Donald Trump’s U.S. presidential election win led investors to conclude the threat of tough action on drug pricing had receded.

Health This Could Be the Next Blockbuster Drug for GlaxoSmithKline GlaxoSmithKline gsk has filed its shingles vaccine Shingrix for U.S. regulatory approval, the drugmaker said on Monday, bringing the potential $1 billion-a-year seller a step closer to market.

Attorney general Loretta Lynch said the department will issue a new plan next week.

Health 35 US States Are Suing This Opioid Maker for Anticompetitive Practices Thirty-five U.S. states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market. The British

CEO Daily NewsletterSign up for CEO Daily to get must-read business news fit for the corner office—plus more.View Sample

Most Popular on FORTUNE

Android Co-Founder Has a Plan to Cure Our Smartphone Addiction

Google Ice Cream Sandwich Debuts As IPhone Sets Record

Android Co-Founder Has a Plan to Cure Our Smartphone Addiction

Carl Icahn Steps Down as Adviser to President Trump

Carl Icahn Steps Down as Adviser to President Trump

This Robocall Lawsuit Means That You Can Receive Up To $900

If You Bought Google at Its IPO Price, Here’s How Much Richer You’d Be

If You Bought Google at Its IPO Price, Here’s How Much Richer You’d Be

Customer Service Site Map Privacy Policy Advertising Ad Choices Terms of Use Your California Privacy Rights Careers

All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions